Skip to content
VuFind
Your Account
Log Out
Login
Language
English
Español
Français
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
TRIB2 confers resistance to an...
Text this
Text this:
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Number:
Provider:
Select your carrier
Alltel
AT&T
Cricket
Nextel
Sprint
T Mobile
Verizon
Virgin Mobile
Loading...